A Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia (cAMeLot-1)

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia (cAMeLot-1)	acute leukemia	Recruiting	Phase 1 / Phase 2	2026-09-25		NCT04811560

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Janssen Research & Development, LLC	188

102 results · Page 1 of 5

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Asan Medical Center	Seoul	South Korea	338
Baylor University Medical Center	Dallas	United States	87
Carmel Medical Center	Haifa	Israel	24
Centre Hospitalier Universitaire (CHU) de Bordeaux Hopital HautLeveque Centre Francois Magendie	Pessac	France	1
China Medical University Hospital	Taichung	Taiwan	24
CHRU de Nancy - Hopitaux de Brabois	Vandœuvre-lès-Nancy	France	4
CHRU Nancy Brabois	Vandœuvre-lès-Nancy	France	8
CHU Bretonneau	Tours	France	10
CHU de Nantes hotel Dieu	Nantes	France	9
CHU Lyon Sud	Pierre-Bénite	France	3
City of Hope	Duarte	United States	238
Clinica Univ. de Navarra	Pamplona	Spain	42
Dana Farber Cancer Institute	Boston	United States	133
First Affiliated Hospital Medical School of Zhejiang University	Hangzhou	China	1
Fox Chase Cancer Center	Philadelphia	United States	259
Fukushima Medical University Hospital	Fukushima	Japan	7
Fundacao Antonio Prudente A C Camargo Cancer Center	São Paulo	Brazil	23
Fundacao Faculdade de Medicina - Instituto do Cancer do Estado de Sao Paulo	São Paulo	Brazil	11
Ghent University Hospital	Ghent	Belgium	57
Gold Coast University Hospital	Southport	Australia	1
Gunmaken Saiseikai Maebashi Hospital	Maebashi	Japan	2
Gustave Roussy	Villejuif	France	119
Guys and St Thomas NHS Foundation Trust	London	United Kingdom	13
Hadassah University Hospita Ein Kerem	Jerusalem	Israel	7
Henan Cancer Hospital	Zhengzhou	China	11

Clinical trials